Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia

Open access

Abstract

Background: Hypertension (HTN), diabetes mellitus (DM), and dyslipidemia (DL) are well-known risk factors of cardiovascular disease (CVD), but not all patients develop CVDs. Studies have been limited investigating genetic risk of CVDs specific to individuals with metabolic diseases. This study aimed to identify disease-specific and/or common genetic loci associated with CVD susceptibility in chronic metabolic disease patients. Methods: We conducted a genome-wide association study (GWAS) of a multiple case–control design with data from the City Cohort within Health EXAminees subcohort of the Korean Genome and Epidemiology Study (KoGES_HEXA). KoGES_HEXA is a population-based prospective cohort of 173,357 urban Korean adults that had health examinations at medical centers. 42,393 participants (16,309 HTN; 5,314 DM; 20,770 DL) were analyzed, and each metabolic disease group was divided into three CVD case-controls: coronary artery disease (CAD), ischemic stroke (IS), and cardio-cerebrovascular disease (CCD). GWASs were conducted for each case–control group with 7,975,321 imputed single nucleotide polymorphisms using the Phase 3 Asian panel from 1000 Genomes Project, by logistic regression and controlled for confounding variables. Genome-wide significant levels were implemented to identify important susceptibility loci. Results: Totaling 42,393 individuals, this study included 16,309 HTN (mean age [SD], 57.28 [7.45]; 816 CAD, 398 IS, and 1,185 CCD cases), 5,314 DM (57.79 [7.39]; 361 CAD, 153 IS, and 497 CCD cases), and 20,770 DL patients (55.34 [7.63]; 768 CAD, 295 IS, and 1,039 CCD cases). Six genome-wide significant CVD risk loci were identified, with relatively large effect sizes: 1 locus in HTN (HTN-CAD: 17q25.3/ CBX8-CBX4 [OR, 2.607; P = 6.37 × 10 −9 ]), 2 in DM (DM-IS: 4q32.3/ MARCH1-LINC01207 [OR, 5.587; P = 1.34 × 10 −8 ], and DM-CCD: 17q25.3/ RPTOR [OR, 3.511; P = 1.99 × 10 −8 ]), and 3 in DL (DL-CAD: 9q22.2/ UNQ6494-LOC101927847 [OR, 2.282; P = 7.78 × 10 −9 ], DL-IS: 3p22.1/ ULK4 [OR, 2.162; P = 2.97 × 10 −8 ], and DL-CCD: 2p22.2/ CYP1B1-CYP1B1-AS1 [OR, 2.027; P = 4.24 × 10 −8 ]). Conclusions: This study identified 6 susceptibility loci and positional candidate genes for CVDs in HTN, DM, and DL patients using an unprecedented study design. 1 locus (17q25.3) was commonly associated with CAD. These associations warrant validation in additional studies for potential therapeutic applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12967-021-02751-3

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study Design. Flow diagram illustrating the study sample selection process and overall study design
Fig. 1 Study Design. Flow diagram illustrating the study sample selection process and overall study designCC BY · PubMed Central
Fig. 2 Manhattan Plots Showing Association Results of the GWASs. Manhattan plots showing association results from the GWASs of CVD in the HTN(A–C), DM(D–F), and DL(G–I) groups within the City Cohort: a HTN-CAD (816 CAD cases and 15,488 controls), b HTN-IS (398 IS cases and 15,909 controls), c HTN-CCD (1,185 CCD cases and 15,117 controls), d DM-CAD (361 CAD cases and 5,161 controls), e DM-IS (153 IS cases and 5,161 controls), f DM-CCD (497 CCD cases and 4,815 controls), g DL-CAD (768 CAD cases and 19,999 controls), h DL-IS (295 IS cases and 20,474 controls), and i DL-CCD (1,039 CCD cases and 19,727 controls). Each tested SNP is visualized as a dot with a location on the genome shown on the x-axis and log10- transformed p values on the y-axis. Results for all chromosomes within the consensus threshold for genome-wide significance (5 × 10−8) are marked with a horizontal line in red and suggestive significance (1 × 10–5) in blue
Fig. 2 Manhattan Plots Showing Association Results of the GWASs. Manhattan plots showing association results from the GWASs of CVD in the HTN(A–C), DM(D–F), and DL(G–I) groups within the City Cohort: a HTN-CAD (816 CAD cases and 15,488 controls), b HTN-IS (398 IS cases and 15,909 controls), c HTN-CCD (1,185 CCD cases and 15,117 controls), d DM-CAD (361 CAD cases and 5,161 controls), e DM-IS (153 IS cases and 5,161 controls), f DM-CCD (497 CCD cases and 4,815 controls), g DL-CAD (768 CAD cases and 19,999 controls), h DL-IS (295 IS cases and 20,474 controls), and i DL-CCD (1,039 CCD cases and 19,727 controls). Each tested SNP is visualized as a dot with a location on the genome shown on the x-axis and log10- transformed p values on the y-axis. Results for all chromosomes within the consensus threshold for genome-wide significance (5 × 10−8) are marked with a horizontal line in red and suggestive significance (1 × 10–5) in blueCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Cited by

See all 41

Metadata

Authors
Song, Y., Choi, J.-E., Kwon, Y.-J., Chang, H.-J., Kim, J. O., Park, D.-H., Park, J.-M., Kim, S.-J., Lee, J. W., & Hong, K.-W.
Affiliations
  • Yonsei University (KR)
  • Theragen (KR)
Corresponding author
  • Lee, Ji Won
  • Hong, Kyung-Won
Venue
Journal of Translational Medicine
Published
2021-02-25
Volume
19
Issue
1
Pages
85-85
ISSN
1479-5876 (ISSN-L)
OpenAlex
W3133250665
Cited by
41
References
59
Citations by year
2026: 9 · 2025: 9 · 2024: 6 · 2023: 7 · 2022: 4 · 2021: 5
FWCI
3.11
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Funders
  • Ministry of Science, ICT and Future Planning (NRF2018R1D1A1B07049223)
  • Ministry of Trade, Industry and Energy (20002781)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
cardiovascular disease susceptibility, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, ischemic stroke, cardio-cerebrovascular disease, genetic susceptibility loci, CCL23, CCL22
MeSH terms
Adult, Cardiovascular Diseases, Coronary Artery Disease, Diabetes Mellitus, Humans, Hypertension, Ligases, Prospective Studies, Risk Factors, Protein Serine-Threonine Kinases, Dyslipidemias, Genome-Wide Association Study, Polycomb-Group Proteins, Polycomb Repressive Complex 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia. https://app.cochat.ai/papers/10.1186/s12967-021-02751-3
The paper
Song, Y., Choi, J.-E., Kwon, Y.-J., Chang, H.-J., Kim, J. O., Park, D.-H., Park, J.-M., Kim, S.-J., Lee, J. W., & Hong, K.-W. (2021). Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia. Journal of Translational Medicine. https://doi.org/10.1186/s12967-021-02751-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.